We track the AI x bio frontier - to help you stay ahead

BAIO is the trusted 5-minute briefing on AI × bio - the news, research, deals, and tools that matter. Get it in your inbox twice a week.

These already read BAIO to stay one step ahead.

Featured

Jun 22, 2026

•

8 min read

What to make of the Midjourney Scanner

Plus: OpenAI revisits rare-disease genomes, Benchling adds private lab context, and AlphaFold’s co-creator heads to Anthropic.

Peter Ottsjö

Scientists are the new refugees in Dario Amodei's world

Jun 11, 2026

•

2 min read

Scientists are the new refugees in Dario Amodei's world

A personal note on Claude Fable, Anthropic’s biology safeguards and the coming fight over access to frontier AI.

Peter Ottsjö

TOP 10

May 29, 2026

•

5 min read

The TOP 10 AI x bio stories in May

World models for proteins, robot hands in the wet lab, AI scientists in Nature, and safety filters that still cannot tell ordinary biology from risky biology.

Peter Ottsjö

Latest

Iambic’s IPO puts Isomorphic’s reported $40 billion valuation in focus

Oct 18, 2026

•

5 min read

Iambic’s IPO puts Isomorphic’s reported $40 billion valuation in focus

Plus: Google’s vision for autonomous labs, NVIDIA’s partnership with Danaher, and AstraZeneca’s deal with insitro.

Peter Ottsjö

This AI turns words into proteins that bind

Oct 15, 2026

•

5 min read

This AI turns words into proteins that bind

Plus: Illumina predicts RNA messages from DNA, Generate’s obesity-drug deal, and AI that helps find genes.

Peter Ottsjö

Here's the $1.8 billion plan to get the data AI needs

Oct 8, 2026

•

6 min read

Here's the $1.8 billion plan to get the data AI needs

Plus: DeepMind’s made-to-order enzymes, Lilly’s animal data powering AI for smaller biotechs, and Utah’s test of AI-written acne prescriptions.

Peter Ottsjö